idoxuridine has been researched along with Colonic Neoplasms in 28 studies
Colonic Neoplasms: Tumors or cancer of the COLON.
Excerpt | Relevance | Reference |
---|---|---|
"To detect and quantify hypoxia in colorectal adenocarcinomas by use of pimonidazole and iododeoxyuridine (IdUrd) as extrinsic markers and carbonic anhydrase IX (CA IX), microvessel density (MVD), epidermal growth-factor receptor (EGFR), and vascular endothelial growth factor (VEGF) as intrinsic markers of hypoxia." | 3.73 | Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers. ( Begg, AC; De Schutter, H; Debucquoy, A; Ectors, N; Geboes, K; Goethals, L; Haustermans, KM; McBride, WH; Penninckx, F; Perneel, C, 2006) |
"The prognosis of colorectal cancer has not significantly changed during the last 30 years." | 1.30 | Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer. ( Bergström, C; Oberg, A; Palmqvist, R; Rutegård, JN; Stenling, R; Zackrisson, B, 1998) |
" Pharmacokinetic analysis of p." | 1.29 | An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116. ( Cheng, YC; Kinsella, TJ; Kunugi, KA; Liu, SH; McCulloch, W; Vielhuber, KA, 1994) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (14.29) | 18.7374 |
1990's | 17 (60.71) | 18.2507 |
2000's | 7 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berry, SE | 1 |
Loh, T | 1 |
Yan, T | 1 |
Kinsella, TJ | 6 |
Shin, JH | 1 |
Chung, JK | 1 |
Kang, JH | 1 |
Lee, YJ | 1 |
Kim, KI | 1 |
Kim, CW | 1 |
Jeong, JM | 1 |
Lee, DS | 1 |
Lee, MC | 1 |
Chi, KH | 1 |
Wang, HE | 1 |
Wang, YS | 1 |
Chou, SL | 1 |
Yu, HM | 1 |
Tseng, YH | 1 |
Hwang, IM | 1 |
Lui, WY | 1 |
Schaffland, AO | 1 |
Delaloye, AB | 1 |
Kosinski, M | 1 |
Dupertuis, YM | 1 |
Buchegger, F | 2 |
Coucke, PA | 1 |
Cottin, E | 1 |
Azria, D | 1 |
Martineau, P | 1 |
Adamer, F | 1 |
Decosterd, LA | 1 |
Do, HP | 1 |
Baranowska-Kortylewicz, J | 2 |
Nearman, J | 1 |
Goethals, L | 1 |
Debucquoy, A | 1 |
Perneel, C | 1 |
Geboes, K | 1 |
Ectors, N | 1 |
De Schutter, H | 1 |
Penninckx, F | 1 |
McBride, WH | 1 |
Begg, AC | 1 |
Haustermans, KM | 1 |
Kunugi, KA | 2 |
Vielhuber, KA | 1 |
McCulloch, W | 1 |
Liu, SH | 1 |
Cheng, YC | 1 |
Rodriguez, R | 2 |
Ritter, MA | 1 |
Fowler, JF | 3 |
Kortylewicz, ZP | 1 |
Hoffman, D | 1 |
Winoto, A | 1 |
Lai, J | 1 |
Dalrymple, GV | 1 |
Palmqvist, R | 1 |
Oberg, A | 1 |
Bergström, C | 1 |
Rutegård, JN | 1 |
Zackrisson, B | 1 |
Stenling, R | 1 |
Glennon, MC | 1 |
Lindstrom, MJ | 1 |
Fritze, D | 1 |
Kern, DH | 1 |
Drogemuller, CR | 1 |
Pilch, YH | 1 |
Birchall, JP | 1 |
Owen, JJ | 1 |
Miller, MA | 2 |
Bokhari, SA | 1 |
Qadir, K | 1 |
Raza, A | 2 |
Miller, EM | 1 |
Lawrence, TS | 3 |
Davis, MA | 3 |
Maybaum, J | 3 |
Stetson, PL | 3 |
Ensminger, WD | 3 |
McKeever, PE | 1 |
Normolle, DP | 1 |
Kelly, SA | 1 |
Gschmeissner, S | 1 |
East, N | 1 |
Balkwill, FR | 1 |
Pedley, RB | 2 |
Begent, RH | 1 |
Boden, JA | 2 |
Boden, R | 1 |
Adam, T | 1 |
Bagshawe, KD | 3 |
Sharma, K | 1 |
Southall, PJ | 1 |
Boxer, GM | 1 |
Patridge, TA | 1 |
Antoniw, P | 1 |
Humm, JL | 1 |
Sharma, SK | 1 |
Boxer, G | 1 |
Mazewski, CM | 1 |
Yousuf, N | 1 |
Sheikh, Y | 1 |
White, LM | 1 |
Yanik, GA | 1 |
Hyams, DM | 1 |
Lampkin, BC | 1 |
Miller, E | 1 |
Calabresi, P | 1 |
Curt, G | 1 |
Okubo, A | 1 |
Sone, S | 1 |
Tanaka, M | 1 |
Ogura, T | 1 |
Shearer, WT | 1 |
Philpott, GW | 1 |
Parker, CW | 1 |
28 other studies available for idoxuridine and Colonic Neoplasms
Article | Year |
---|---|
Role of MutSalpha in the recognition of iododeoxyuridine in DNA.
Topics: Adaptor Proteins, Signal Transducing; Base Pair Mismatch; Carrier Proteins; Cell Nucleus; Colonic Ne | 2003 |
Feasibility of sodium/iodide symporter gene as a new imaging reporter gene: comparison with HSV1-tk.
Topics: Animals; Biomarkers, Tumor; Cell Line, Tumor; Colonic Neoplasms; Feasibility Studies; Gene Expressio | 2004 |
Antisense thymidylate synthase electrogene transfer to increase uptake of radiolabeled iododeoxyuridine in a murine model.
Topics: Adenocarcinoma; Animals; BALB 3T3 Cells; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; DNA, Antis | 2004 |
The preparation of clinical grade 5-[123I]iodo-2'-deoxyuridine and 5-[125I]iodo-2'-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy.
Topics: Animals; Cell Division; Colonic Neoplasms; Feasibility Studies; Female; Humans; Idoxuridine; Iodine | 2004 |
Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Deoxycytidine; | 2004 |
DNA uptake of 131I-iododeoxyuridine.
Topics: Adenocarcinoma; Animals; BALB 3T3 Cells; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; DNA, Antis | 2005 |
Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Biomarkers; Carbonic Anhydrase | 2006 |
An in vivo comparison of oral 5-iodo-2'-deoxyuridine and 5-iodo-2-pyrimidinone-2'-deoxyribose toxicity, pharmacokinetics, and DNA incorporation in athymic mouse tissues and the human colon cancer xenograft, HCT-116.
Topics: Administration, Oral; Animals; Colonic Neoplasms; DNA; Female; Humans; Idoxuridine; Liver; Liver Neo | 1994 |
Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
Topics: Animals; Carcinoma; Cell Cycle; Cell Line; Colonic Neoplasms; DNA, Neoplasm; Dose-Response Relations | 1994 |
Colon-specific prodrugs of 5-radioiodo-2'-deoxyuridine.
Topics: Administration, Oral; Animals; beta-Galactosidase; beta-Glucosidase; Colonic Neoplasms; Digestive Sy | 1996 |
Systematic heterogeneity and prognostic significance of cell proliferation in colorectal cancer.
Topics: Cecal Neoplasms; Cell Division; Colonic Neoplasms; Colorectal Neoplasms; Female; Flow Cytometry; Hum | 1998 |
In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
Topics: Animals; Colonic Neoplasms; Dideoxynucleosides; DNA; Dose-Response Relationship, Drug; Female; HT29 | 1996 |
A new micromethod for the detection of HL-A antigens on cultured human tumor cells.
Topics: Adenocarcinoma; Antibody Specificity; Colonic Neoplasms; Culture Techniques; Cytotoxicity Tests, Imm | 1975 |
An [125I]iododesoxyuridine utilization assay to measure the survival of human cells after various freezing programs.
Topics: Cell Survival; Colonic Neoplasms; DNA; Female; Freezing; Humans; Idoxuridine; Neoplasms; Ovarian Neo | 1979 |
Simultaneous assessment of TGFB and cell cycle kinetics using IUdR/BrdU infusions in human neoplasms from plastic-embedded tissue.
Topics: Antibodies, Monoclonal; Biopsy; Bone Marrow; Breast Neoplasms; Bromodeoxyuridine; Cell Cycle; Coloni | 1992 |
Linear-quadratic analysis of radiosensitization by halogenated pyrimidines. I. Radiosensitization of human colon cancer cells by iododeoxyuridine.
Topics: Cell Survival; Colonic Neoplasms; Dose-Response Relationship, Radiation; Humans; Idoxuridine; In Vit | 1992 |
Modulation of iododeoxyuridine-mediated radiosensitization by 5-fluorouracil in human colon cancer cells.
Topics: Cell Cycle; Colonic Neoplasms; DNA, Neoplasm; Fluorouracil; Humans; Idoxuridine; In Vitro Techniques | 1992 |
Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
Topics: Animals; Cell Cycle; Colonic Neoplasms; DNA Damage; DNA Repair; DNA, Neoplasm; Dose-Response Relatio | 1991 |
Enhancement of metastatic potential by gamma-interferon.
Topics: Adenocarcinoma; Animals; Antibodies; Cell Adhesion; Cell Division; Colonic Neoplasms; Extracellular | 1991 |
The effect of radiosensitizers on radio-immunotherapy, using 131I-labelled anti-CEA antibodies in a human colonic xenograft model.
Topics: Animals; Antibodies, Monoclonal; Carcinoembryonic Antigen; Colonic Neoplasms; Humans; Idoxuridine; I | 1991 |
Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
Topics: Adenocarcinoma; Animals; Cell Line; Choriocarcinoma; Colon; Colonic Neoplasms; Cytarabine; Drug Resi | 1991 |
Tissue dose estimates following the selective uptake of 125IUdR and other radiolabelled thymidine precursors in resistant tumours.
Topics: Adenocarcinoma; Animals; Astatine; Bromine Radioisotopes; Cell Nucleus; Cell Survival; Choriocarcino | 1991 |
Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.
Topics: Antibodies, Monoclonal; Brain Neoplasms; Bromodeoxyuridine; Cell Cycle; Colonic Neoplasms; Humans; I | 1991 |
Continuous infusion of halogenated pyrimidines.
Topics: Colonic Neoplasms; Combined Modality Therapy; Humans; Idoxuridine; In Vitro Techniques; Radiation-Se | 1991 |
Incorporation of iododeoxyuridine into neoplastic DNA: a fraudulent magic bullet?
Topics: Cell Survival; Colonic Neoplasms; DNA, Neoplasm; Humans; Idoxuridine; Liver; Liver Neoplasms; Thymid | 1990 |
The effect of single versus double-strand substitution on halogenated pyrimidine-induced radiosensitization and DNA strand breakage in human tumor cells.
Topics: Bromodeoxyuridine; Cell Line; Cell Survival; Colonic Neoplasms; DNA; DNA Damage; DNA, Neoplasm; DNA, | 1990 |
Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Cell Communication; Cell Line; Cell Membrane; Colonic Neoplasms; | 1989 |
Stimulation of cells by antibody.
Topics: Animals; Antibodies, Neoplasm; Carcinoma; Cell Line; Colonic Neoplasms; Cross Reactions; DNA, Neopla | 1973 |